[ad_1]
The whole lot we coated on IAM over the past seven days – and all you could know from the worldwide IP market to set your self up for the beginning of one other busy week.
MONDAY 19 FEBRUARY
India – the rising sun of SEP enforcement in 2024
How courts world wide are tackling AI, SEPs and software eligibility
Knowledge dive: Meet the Irish NPE that’s suing automakers and tech companies
TUESDAY 20 FEBRUARY
Delhi Excessive Courtroom backpedals in landmark pharma ruling on product-by-process claims
Avanci signs Volkswagen Group to fast-growing 5G programme
Seven key takeaways from Nokia’s disputes with Oppo and Vivo
WEDNESDAY 21 FEBRUARY
Interview: mRNA trade secrets to become even more important, says WHO vaccine hub boss
Interview: Fractus’ first IoT deal will hopefully drive further agreements, says SME’s licensing VP
Knowledge dive: Preliminary injunction practice at Brazil’s main patent courts
Adeia studies first full year of earnings on again of 32 patent licence offers
THURSDAY 22 FEBRUARY
Interview: Kathi Vidal supplies updates on six crucial US patent policy initiatives
mRNA corporations and different biopharma patentees dominate ‘Innovation Momentum’ rankings
FRIDAY 23 FEBRUARY
Knowledge dive: The top USPTO representatives of 2023
InterDigital’s newest win towards Oppo showcases India’s attractiveness for SEP house owners
Landmines for the unwary within the USPTO’s steerage on AI-assisted innovations
Commerce secrets and techniques: Classes from a leading trade secrets litigator
SATURDAY 24 FEBRUARY
Opinion: The European Fee’s SEPs proposal is an own goal. It must be rejected.
[ad_2]
Source link
